The lymphocyte, the plasma cell and the cells of the reticuloendothelial system have been described as sites of antibody formation in animals (1) (2) (3) (4) (5) . Since the malignant lymphomata in man are often associated with an increase in the number of these cells, studies were initiated to determine if abnormalities in antibody response occurred in patients with leukemia, lymphosarcoma or Hodgkin's disease.
Several reports have appeared in the literature describing the ability to form antibodies in patients with leukemia and related diseases. Antigens used have included typhoid organisms (6-9), vibrio vaccine (10) , and horse serum (11, 12) . Antibody responses, measured by methods based on serum dilution techniques, suggested an impairment of antibody formation in patients with chronic leukemia, especially in those with chronic lymphatic leukemia. Heterophile antibody titers have been studied in patients with leukemia and allied diseases, and the data have recently been reviewed (13, 14) . The evidence indicates that the incidence of elevated heterophile antibody titers is not increased in the leukemias. The purpose of this communication is to report observations on antibody formation in human leukemia, lymphosarcoma and Hodgkin's disease, using the quantitative precipitin technique developed by Heidelberger and his associates (15 usually little change in the levels of C-antibody during. the test period ( 15, 16) . Nine of 11 patients with untreated acute leukemia produced unusually large amounts of antibody to at least one of the antigens (Table II) . Pati nt 71 was an adult who entered a spontaneous temporary remission during the test period and formed very little antibody. As is shown in Table  III , the seven patients with acute leukemia who Table I. were treated with cortisone showed antibody responses which were often well above the normal range but appeared to be considerably lower than in the untreated group. In Table IV 
DISCUSSION
The pneumococcus polysaccharide-anti-polysaccharide system has several features which make it different from many other antigen-antibody systems. The antigen is non-protein and it fails to stimulate antibody formation in the rabbit (18) . In man, elevated antibody titers may persist for years following a single antigenic stimulation, and in these individuals, an anamnestic response does not occur (19) . For these reasons information on antibody response obtained in man using the pneumococcus polysaccharides does not necessarily apply to other antigen-antibody systems or to other species.
The ability to form antibodies to the pneumococcus capsular polysaccharides in these studies appeared to be influenced by the type of leukemia present. Individuals with acute leukemia had the largest number of immature white blood cells in their peripheral blood and bone marrow, and were also noted to have the largest antibody responses. There was no apparent relation between the total white blood cell count in the peripheral blood and the amount of antibody produced. The data do raise the possibility that, in man, the immature white blood cell may play a role in the formation (16) . In the present studies, cortisone administration to patients with acute leukemia was associated with the production of smaller amounts of antibody than was observed in the group of patients with acute leukemia who Antibody formation to pneumococcus capsular polysaccharides I and II has been studied in a group of human subjects with leukemia and other lymphomatous disease, using quantitative immunochemical techniques. Nine of 11 patients with untreated acute leukemia had unusually large antibody responses. These responses were impaired in seven patients with acute leukemia receiving cortisone. Eight of nine patients with chronic lymphatic leukemia exhibited little or no antibody response. Seven patients with chnonic myeloid leukemia, three patients with Hodgkin's disease, and four patients with lymphosarcoma had antibody responses essentially within the normal range.
